269 related articles for article (PubMed ID: 27183870)
1. Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysis.
Tao LY; Zhang LF; Xiu DR; Yuan CH; Ma ZL; Jiang B
World J Surg Oncol; 2016 May; 14():146. PubMed ID: 27183870
[TBL] [Abstract][Full Text] [Related]
2. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.
Li T; Zheng Y; Sun H; Zhuang R; Liu J; Liu T; Cai W
Med Oncol; 2016 Jul; 33(7):61. PubMed ID: 27225938
[TBL] [Abstract][Full Text] [Related]
3. Is K-ras gene mutation a prognostic factor for colorectal cancer: a systematic review and meta-analysis.
Ren J; Li G; Ge J; Li X; Zhao Y
Dis Colon Rectum; 2012 Aug; 55(8):913-23. PubMed ID: 22810479
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
5. Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
Olsen CC; Schefter TE; Chen H; Kane M; Leong S; McCarter MD; Chen Y; Mack P; Eckhardt SG; Stiegmann G; Raben D
Am J Clin Oncol; 2009 Apr; 32(2):115-21. PubMed ID: 19307945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.
Vincenzi B; Cremolini C; Sartore-Bianchi A; Russo A; Mannavola F; Perrone G; Pantano F; Loupakis F; Rossini D; Ongaro E; Bonazzina E; Dell'Aquila E; Imperatori M; Zoccoli A; Bronte G; De Maglio G; Fontanini G; Natoli C; Falcone A; Santini D; Onetti-Muda A; Siena S; Tonini G; Aprile G
Oncotarget; 2015 Oct; 6(31):31604-12. PubMed ID: 26384309
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
Ogura T; Yamao K; Hara K; Mizuno N; Hijioka S; Imaoka H; Sawaki A; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
J Gastroenterol; 2013 May; 48(5):640-6. PubMed ID: 22983505
[TBL] [Abstract][Full Text] [Related]
8. KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review.
Kim BJ; Jang HJ; Kim JH; Kim HS; Lee J
Oncotarget; 2016 Sep; 7(36):58001-58006. PubMed ID: 27517148
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.
Liu SL; Chen G; Zhao YP; Wu WM; Zhang TP
Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):458-64. PubMed ID: 24103274
[TBL] [Abstract][Full Text] [Related]
10. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.
Zhuang R; Li S; Li Q; Guo X; Shen F; Sun H; Liu T
PLoS One; 2017; 12(8):e0182562. PubMed ID: 28796802
[TBL] [Abstract][Full Text] [Related]
12. K-ras mutations in the plasma correspond to computed tomographic findings in patients with pancreatic cancer.
Däbritz J; Preston R; Hänfler J; Oettle H
Pancreas; 2012 Mar; 41(2):323-5. PubMed ID: 22044911
[No Abstract] [Full Text] [Related]
13. A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.
Yang J; Li S; Li J; Wang F; Chen K; Zheng Y; Wang J; Lu W; Zhou Y; Yin Q; Zhang H; Guo C
Pancreatology; 2016; 16(4):605-14. PubMed ID: 27237100
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.
Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
[TBL] [Abstract][Full Text] [Related]
16. Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.
Marchese R; Muleti A; Pasqualetti P; Bucci B; Stigliano A; Brunetti E; De Angelis M; Mazzoni G; Tocchi A; Brozzetti S
Pancreas; 2006 Mar; 32(2):171-7. PubMed ID: 16552337
[TBL] [Abstract][Full Text] [Related]
17. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of circulating tumor DNA in pancreatic cancer: a systematic review and meta-analysis.
Fang Z; Meng Q; Zhang B; Shi S; Liu J; Liang C; Hua J; Yu X; Xu J; Wang W
Aging (Albany NY); 2020 Dec; 13(2):2031-2048. PubMed ID: 33318293
[TBL] [Abstract][Full Text] [Related]
19. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras gene mutation by liquid biopsy in patients with pancreatic cancer.
Kinugasa H; Nouso K; Miyahara K; Morimoto Y; Dohi C; Tsutsumi K; Kato H; Matsubara T; Okada H; Yamamoto K
Cancer; 2015 Jul; 121(13):2271-80. PubMed ID: 25823825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
